BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 37795668)

  • 1. Burden of Episodic Migraine, Chronic Migraine, and Medication Overuse Headache in Alberta.
    McMullen S; Graves E; Ekwaru P; Pham T; Mayer M; Ladouceur MP; Hubert M; Bougie J; Amoozegar F
    Can J Neurol Sci; 2023 Oct; ():1-11. PubMed ID: 37795668
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevention of medication overuse and medication overuse headache in patients with migraine: a randomized, controlled, parallel, allocation-blinded, multicenter, prospective trial using a mobile software application.
    Diener HC; Donoghue S; Gaul C; Holle-Lee D; Jöckel KH; Mian A; Schröder B; Kühl T
    Trials; 2022 May; 23(1):382. PubMed ID: 35546412
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The burden of medication overuse headache and patterns of switching and discontinuation among triptan users: a systematic literature review.
    Deighton AM; Harris LA; Johnston K; Hogan S; Quaranta LA; L'Italien G; Coric V
    BMC Neurol; 2021 Nov; 21(1):425. PubMed ID: 34727873
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preventive migraine treatment with eptinezumab reduced acute headache medication and headache frequency to below diagnostic thresholds in patients with chronic migraine and medication-overuse headache.
    Marmura MJ; Diener HC; Cowan RP; Tepper SJ; Diamond ML; Starling AJ; Hirman J; Mehta L; Brevig T; Cady R
    Headache; 2021 Oct; 61(9):1421-1431. PubMed ID: 34551130
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipopolysaccharide, VE-cadherin, HMGB1, and HIF-1α levels are elevated in the systemic circulation in chronic migraine patients with medication overuse headache: evidence of leaky gut and inflammation.
    Vuralli D; Ceren Akgor M; Gok Dagidir H; Gulbahar O; Yalinay M; Bolay H
    J Headache Pain; 2024 Feb; 25(1):23. PubMed ID: 38369488
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Headache characteristics and burden from chronic migraine with medication overuse headache: Cross-sectional observations from the Medication Overuse Treatment Strategy trial.
    Schwedt TJ; Hentz JG; Sahai-Srivastava S; Spare NM; Martin VT; Treppendahl C; Digre K; Bennett NL; Birlea M; Watson D; Murinova N; Robert T; Dodick DW;
    Headache; 2021 Feb; 61(2):351-362. PubMed ID: 33432635
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced functional connectivity between habenula and salience network in medication-overuse headache complicating chronic migraine positions it within the addiction disorders: an ICA-based resting-state fMRI study.
    Dai W; Qiu E; Chen Y; Xing X; Xi W; Zhang M; Li K; Tian L; Dong Z; Yu S
    J Headache Pain; 2021 Sep; 22(1):107. PubMed ID: 34503441
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characteristics of Adults with Migraine in Alberta, Canada: A Population-Based Study.
    Richer L; Wong KO; Martins KJB; Rajapakse T; Amoozegar F; Becker WJ; Klarenbach SW
    Can J Neurol Sci; 2022 Mar; 49(2):239-248. PubMed ID: 33845936
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Medication-overuse headache.
    Tepper SJ
    Continuum (Minneap Minn); 2012 Aug; 18(4):807-22. PubMed ID: 22868543
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Assessment of Clinical Characteristics, Treatment Patterns, and Burden of Illness in Patients With Episodic and Chronic Migraine: A Cross-Sectional Study.
    Irfan S; Mohammed F; Hameed S; Ravi V; V K; S S; Arumugam S; Subramanian B; Ravichandran S; Ravichandran U
    Cureus; 2024 Apr; 16(4):e59073. PubMed ID: 38800196
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Obsessive-compulsive disorder and migraine with medication-overuse headache.
    Cupini LM; De Murtas M; Costa C; Mancini M; Eusebi P; Sarchielli P; Calabresi P
    Headache; 2009 Jul; 49(7):1005-13. PubMed ID: 19496831
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Medication overuse headache in patients with chronic migraine using cannabis: A case-referent study.
    Zhang N; Woldeamanuel YW
    Headache; 2021 Sep; 61(8):1234-1244. PubMed ID: 34370866
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy, tolerability, and safety of eptinezumab in patients with a dual diagnosis of chronic migraine and medication-overuse headache: Subgroup analysis of PROMISE-2.
    Diener HC; Marmura MJ; Tepper SJ; Cowan R; Starling AJ; Diamond ML; Hirman J; Mehta L; Brevig T; Sperling B; Cady R
    Headache; 2021 Jan; 61(1):125-136. PubMed ID: 33314079
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unsatisfactory response to acute medications does not affect the medication overuse headache development in pediatric chronic migraine.
    Frattale I; Ferilli MAN; Ursitti F; Sforza G; Monte G; Proietti Checchi M; Tarantino S; Mazzone L; Valeriani M; Papetti L
    J Headache Pain; 2024 Apr; 25(1):61. PubMed ID: 38649822
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The transition of medication overuse status by acute medication categories in episodic or chronic migraine patients to non-overuse status after receiving anti-CGRP monoclonal antibodies: a systematic review and meta-analysis of phase 3 randomized control trial.
    Sirilertmekasakul C; Panto A; Lekhalawan P; Panyarachun P; Jindasakchai P; Rattanawong W
    Neurol Sci; 2024 Apr; ():. PubMed ID: 38564060
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of medication overuse (MO) and medication overuse headache (MOH) S1 guideline.
    Diener HC; Kropp P; Dresler T; Evers S; Förderreuther S; Gaul C; Holle-Lee D; May A; Niederberger U; Moll S; Schankin C; Lampl C
    Neurol Res Pract; 2022 Aug; 4(1):37. PubMed ID: 36031642
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of Relationship Between Childhood Maltreatment and Medication Overuse Headache.
    Altintaş E; Karakurum Göksel B; Saritürk Ç; Taşkintuna N
    Noro Psikiyatr Ars; 2015 Sep; 52(3):267-271. PubMed ID: 28360722
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantity changes in acute headache medication use among patients with chronic migraine treated with eptinezumab: subanalysis of the PROMISE-2 study.
    Cowan RP; Marmura MJ; Diener HC; Starling AJ; Schim J; Hirman J; Brevig T; Cady R
    J Headache Pain; 2022 Sep; 23(1):115. PubMed ID: 36068494
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Critical Evaluation on MOH Current Treatments.
    Negro A; Curto M; Lionetto L; Guerzoni S; Pini LA; Martelletti P
    Curr Treat Options Neurol; 2017 Aug; 19(9):32. PubMed ID: 28808924
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment pattern and health care resource utilization for Taiwanese patients with migraine: a population-based study.
    Wang YF; Wang SJ; Huang YH; Chen YT; Yen YC; Shia BC; Tsai CW; Chan HF; Panni T; Dell'Agnello G
    Front Neurol; 2023; 14():1222912. PubMed ID: 37654430
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.